GOLDMAN SACHS GROUP INC - T2 BIOSYSTEMS INC ownership

T2 BIOSYSTEMS INC's ticker is TTOO and the CUSIP is 89853L104. A total of 55 filers reported holding T2 BIOSYSTEMS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of T2 BIOSYSTEMS INC
ValueSharesWeighting
Q3 2022$25,000
-32.4%
226,905
+0.0%
0.00%
Q2 2022$37,000
-68.9%
226,807
+0.0%
0.00%
Q1 2022$119,000
-87.6%
226,805
-87.8%
0.00%
Q4 2021$960,000
-75.9%
1,858,845
-57.4%
0.00%
-100.0%
Q3 2021$3,989,000
-23.1%
4,358,825
+0.0%
0.00%0.0%
Q2 2021$5,187,000
-26.5%
4,358,8170.0%0.00%
-50.0%
Q1 2021$7,061,000
+30.6%
4,358,8170.0%0.00%
+100.0%
Q4 2020$5,405,000
-8.8%
4,358,8170.0%0.00%
-50.0%
Q3 2020$5,928,000
+7.1%
4,358,8170.0%0.00%0.0%
Q2 2020$5,536,000
+95.5%
4,358,8170.0%0.00%
+100.0%
Q1 2020$2,831,000
-44.1%
4,358,817
+0.8%
0.00%0.0%
Q4 2019$5,060,000
-53.2%
4,324,6290.0%0.00%
-66.7%
Q3 2019$10,811,000
+48.8%
4,324,6290.0%0.00%
+50.0%
Q2 2019$7,265,000
-35.8%
4,324,629
+0.5%
0.00%
-33.3%
Q1 2019$11,316,000
-12.4%
4,302,629
+0.3%
0.00%
-25.0%
Q4 2018$12,911,000
-59.6%
4,289,3400.0%0.00%
-50.0%
Q3 2018$31,955,000
-3.7%
4,289,3400.0%0.01%
-11.1%
Q2 2018$33,199,000
+19.5%
4,289,340
+0.2%
0.01%
+28.6%
Q1 2018$27,779,000
+57.9%
4,280,340
+0.2%
0.01%
+75.0%
Q4 2017$17,595,000
-1.9%
4,270,6320.0%0.00%0.0%
Q3 2017$17,937,000
+30.8%
4,270,6320.0%0.00%0.0%
Q2 2017$13,709,000
-38.7%
4,270,632
+0.4%
0.00%
-33.3%
Q1 2017$22,369,0000.0%4,252,632
+0.0%
0.01%0.0%
Q4 2016$22,369,000
-27.3%
4,252,6160.0%0.01%
-33.3%
Q3 2016$30,789,000
-8.2%
4,252,6160.0%0.01%
-18.2%
Q2 2016$33,553,000
-19.4%
4,252,616
+0.7%
0.01%
-21.4%
Q1 2016$41,642,000
-8.8%
4,223,416
+1.2%
0.01%0.0%
Q4 2015$45,673,000
+50.0%
4,174,887
+20.1%
0.01%
+40.0%
Q3 2015$30,441,000
-46.0%
3,474,8990.0%0.01%
-41.2%
Q2 2015$56,397,000
+5.1%
3,474,899
+0.5%
0.02%0.0%
Q1 2015$53,657,000
-19.3%
3,457,252
-0.0%
0.02%
-19.0%
Q4 2014$66,519,000
+6.4%
3,457,325
+0.0%
0.02%
+5.0%
Q3 2014$62,541,0003,457,2400.02%
Other shareholders
T2 BIOSYSTEMS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 1,841,924$13,722,0006.87%
Senvest Management, LLC 2,769,931$20,636,0001.56%
Bell Rock Capital LLC 291,835$2,176,0001.07%
ARDSLEY ADVISORY PARTNERS LP 935,000$6,966,0000.94%
TIGER MANAGEMENT L.L.C. 967,585$7,209,0000.72%
ESSEX INVESTMENT MANAGEMENT CO LLC 677,433$5,047,0000.59%
THOMPSON DAVIS & CO., INC. 33,153$247,0000.54%
PERKINS CAPITAL MANAGEMENT INC 69,700$519,0000.31%
Schonfeld Strategic Advisors LLC 322,700$2,404,0000.11%
Phoenix Investment Adviser LLC 8,000$60,0000.08%
View complete list of T2 BIOSYSTEMS INC shareholders